推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-54106218，021-33363733

chinasupport@letpub.com

登录 注册 新注册优惠

[PDF] Pilot Study on Continuous Hyperfractionated Accelerated Radiotherapy (CHART) and High Dose Rate Brachytherapy in Locally Advanced Cervical Cancer

[PDF] from omicsonline.orgBM Biswal, NM Ahmad, ZA Hanafia… - J Cancer Sci …, 2011 - omicsonline.org
... (2000) Modified partial hyperfractionation in radiotherapy ... (2011) Pilot Study on Continuous
Hyperfractionated Accelerated Radiotherapy (CHART ... Parmar MK, Dische S, Chart Trial
Collaborators (2010) Mature results of a randomized trial of accelerated hyperfractionated versus ...
View as HTML

Long-Term Results of a Phase II Trial of Induction Paclitaxel-Carboplatin Followed by Concurrent Radiation Therapy and Weekly Paclitaxel and Consolidation …

F Casas, N Viñolas, F Ferrer, C Agustí… - Journal of Thoracic …, 2011 - journals.lww.com
... results of a phase II study on the use of induction chemotherapy (CHT) using paclitaxel
(P)-carboplatin (C) followed by a concurrent radiation therapy (RT) and ... P 175 mg/m 2 , day 1
and C, area under the curve 6, day 1, given at 3-week interval), after which accelerated RT with ...
Related articles - All 4 versions

… in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non–Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) …

M Werner-Wasik, R Paulus, WJ Curran, Jr… - Clinical Lung …, 2011 - CIG Media Group
... Atelectasis None RL Some 1.690 (1.006-2.839) .0474 Total RT dose Continuous 1.053
(1.014-1.094) .0068 ... Abbreviations: HFX hyperfractionated; NS not significant; RT radiation
therapy. ... In murine experiments,17 a protective effect of hyperfractionation vs. ...
Related articles - All 3 versions

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non …

[HTML] from thegreenjournal.comM Baumann, T Herrmann, R Koch… - Radiotherapy and …, 2011 - Elsevier
... f Department of Radiation Therapy, Städtisches Klinikum Görlitz GmbH, Germany. ... Continuous
hyperfractionated accelerated radiotherapy (CHART) counteracts repopulation and may
significantly improve outcome of patients with non-small-cell lung cancer (NSCLC). ...

Phase 2 trial of concurrent 5‐fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity‐modulated radiation therapy for locally advanced head and neck …

J Kao, EM Genden, V Gupta, EL Policarpio… - Cancer, 2011 - Wiley Online Library
... All patients received concurrent chemoradiotherapy, which consisted of continuous-infusion
5-FU at a dose of 600 mg/m 2 daily for 120 hours, hydroxyurea 500 mg orally every 12 hours
with the morning dose administered 2 ... Hyperfractionated or accelerated radiotherapy in ...
Cited by 11 - Related articles - All 3 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451